Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 91 results for "biocon under kiran mazumdar shaw"

Biocon Announces Q1 FY15 Results

Commenting on the quarterly performance and highlights, Chairman and Managing Director, Kiran Mazumdar-Shaw stated, Our revenue growth this quarter has been muted. Our business performance reflects the challenges that we are temporarily facing in ... Businessworld India, 4 days ago
Biocon : announces Q1 FY15 results... 4 Traders, 4 days ago

68 images for biocon under kiran mazumdar shaw

Financial Express, 4 days ago
NDTV, 1 day ago
Rediff.com, 1 week ago
Reuters, 3 weeks ago
New Indian Express, 3 days ago
Asian Scientist, 3 weeks ago
Asian Lite, 1 month ago
News India Times, 1 month ago
Business Today India, 1 month ago
Forbes India, 1 month ago
Financial Express

NPPA's unilateral stand-off unhealthy for sector: Biocon

CII National Committee on Biotechnology Chairperson and Biocon CMD Kiran Mazumdar Shaw has written an open letter to the Prime Minister, seeking his intervention over "unilateral fixing" of drug prices by NPPA . The government has to behave like ...
 Moneycontrol.com1 day ago Kiran Mazumdar-Shaw urges PM Narendra Modi to cure pharma sector  Financial Express3 days ago Kiran Mazumdar-Shaw awarded Kiel Institute's 2014 Global Economy Prize  Topnews.in1 month ago Biocon chief Kiran Mazumdar-Shaw gets Kiel Institute's '2014 Global Economy Prize  PharmaBiz1 month ago
[x]  
NDTV Profit

Industry Body Seeks Prime Minister's Intervention Over Drug Price Fixing

File photo of Biocon chief Kiran Mazumdar-Shaw New Delhi : Industry chamber CII has sought Prime Minister Narendra Modi's intervention over "unilateral fixing" of drug prices by the National Pharmaceutical Pricing Authority (NPPA) saying the ...
 NDTV Profit1 day ago

Biocon extends pact between Syngene and Bristol-Myer for five more years

Bangalore-based Biocon Ltd, India's largest biotechnology company founded by Kiran Mazumdar-Shaw in 1978, has announced a five-year extension of its drug discovery and development collaboration in India between its contract research subsidiary ...
 VC Circle1 month ago BIOCON : Kiran Mazumdar-Shaw Receives Coveted 'Othmer Gold Medal 2014' from Chemical Heritage Foundation...  4 Traders2 months ago Kiran Mazumdar-Shaw Receives Coveted Othmer Gold Medal 2014 from Chemical Heritage Foundation  Businessworld India2 months ago
PRWeb

Biocon : USP Congratulates Kiran Mazumdar-Shaw, Recipient of 2014 Othmer Gold Medal

The U.S. Pharmacopeial Convention (USP) congratulates Kiran Mazumdar-Shaw on receipt of the 2014 Othmer Gold Medal. Established by the Chemical Heritage Foundation (CHF) in 1997, the award honors outstanding individuals who have made multifaceted ...
 4 Traders2 months ago USP Congratulates Kiran Mazumdar-Shaw, Recipient of 2014 Othmer Gold...  PRWeb2 months ago
[x]  
Moneycontrol.com

Price control debate: Is the pharma sector crying 'wolf'?

T Also Read: See more drug price caps; max impact on Sanofi: Expert CNBC-TV18's Shereen Bhan spoke to Kiran Mazumdar Shaw, CMD of Biocon and Mr CM Gulati, Researcher at IMS Health India to get their perspective on how the government's new move ...
 Moneycontrol.com1 week ago
Forbes India

Kiran Mazumdar-Shaw: Time for Technology-Driven Smart Governance

For this, the new government will need to move away from over-regulation to a system of self-regulation Kiran Mazumdar-Shaw Chairman & Managing Director, Biocon. She heads India's largest listed biotech company. Under her ...
 Forbes India2 months ago

Biocon chief seeks PM's intervention to solve issues being faced by pharma industry

The National Pharmaceutical Pricing Authority's (NPPA) decision to impose ceiling prices on 348 essential drugs under the National List of Essential Medicines (NLEM), by adopting a simple average price formula, has been to the industry's ...
 PharmaBiz1 day ago
Sify

Biocon net up by 10% in Q1 to Rs. 103 crore

Biocon, a Rs. 2,850 crore plus fully integrated, innovation-led, emerging global biopharmaceutical company from Bengaluru, has posted net profit growth of 9.6 per cent for the first quarter ended June 2014 to Rs. 103 crore from Rs. 94 crore in the ...
 PharmaBiz4 days ago Biocon Q1 net up 9%  Business Standard India5 days ago

BIOCON : files first new drug applications

Mumbai : Bangalore -based Biocon on Friday said it has filed its first abbreviated new drug applications (ANDAs) targeting the US generics market during the June quarter. Kiran Mazumdar-Shaw , chairman and managing director, said, "We have filed ...
 4 Traders1 day ago Biocon files its first new drug applications  DNA India3 days ago Biocon files first new drug applications [DNA : Daily News & Analysis (India)]  Pharmacy Choice1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon under kiran mazumdar shaw
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less